AGP Picks
View all

New Hampshire STEM News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Hampshire STEM News.

Press releases published on November 12, 2026

LEQEMBI® Pen (Subcutaneous Formulation of LEQEMBI®) Now Available in Japan for Patients with Early Alzheimer’s Disease
Windward Bio Announces Pricing of Initial Public Offering
Quantum Cyber Reports First Revenue of ~$1.0 Million and Announces $8.0 Million Funding Commitment From Chief Executive Officer David Lazar
POTS Phase 2 Trial Shows Baloncibart, a First-in-Class NPR1 Blocking Antibody, Reduced Orthostatic Heart Rate and Improved Orthostatic Symptoms
SalesHood MCP Brings Trusted Revenue Enablement into the AI Tools Sales Teams Already Use
Longeveron Announces 2026 Third Quarter Financial Results and Provides Business Update
AirJoule Technologies Schedules Release of Third Quarter 2026 Results and Conference Call
Eledon Pharmaceuticals Reports Third Quarter 2026 Financial Results and Recent Business Highlights
3D Systems Celebrates 40 Years During Formnext 2026
Sutro Biopharma Reports Third Quarter 2026 Financial Results and Business Highlights
Correction to the Annual General Meeting Venue Address
New Drug Application Submission Completed for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer
Praxis Precision Medicines Details Launch Readiness for Relutrigine and Ulixacaltamide and Outlines Expanded Pipeline in Preparation to be the Preeminent CNS Biotech at Investor Day
Aeluma Announces First Quarter Fiscal 2027 Financial Results
Future Technologies Expands Licensed Microwave Support to Help Cambium Legacy Customers Protect Network Investments
authID Reports Financial and Operating Results for the Third Quarter 2026
Serina Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates 
BioCardia Reports Third Quarter 2026 Business Highlights and Financial Results
Theriva™ Biologics presenta los aspectos operativos más destacados y los resultados financieros del tercer trimestre de 2026
Verrica Pharmaceuticals Reports Third Quarter 2026 Financial Results

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

New Hampshire STEM News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.